Scott Harris, MS, RAC
Vice President, Regulatory Affairs and Business Operations
Scott Harris, MS, RAC is vice president of regulatory affairs and business operations at CoA Therapeutics. Prior to joining the company, he worked for eight years at Adynxx where he served as executive vice president of regulatory affairs and technical operations. While at Adynxx, Scott oversaw the development of the company’s lead compound from pre-clinical through Phase 2 clinical studies and was responsible for global regulatory affairs, quality assurance and CMC. Scott brings more than 20 years of experience in the industry, starting as a basic scientist in the area of cell and tumor biology, before moving into drug development roles. He has held positions of increasing responsibility at Biosite, Angstrom Pharmaceutical, Attenuon, BioMarin Pharmaceutical and his own independent consulting business. He was also head of regulatory affairs and quality assurance for Corthera until its acquisition by Novartis. Scott currently holds an academic appointment at San Diego State University where he teaches undergraduate and graduate courses in healthcare product regulation. He received his MS in regulatory affairs from San Diego State University and his BS in biochemistry and cell biology from UC San Diego.